This post has been de-listed
It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.
According to the official website for the trial itâs not expected to be completed until early 2026 correct? So either BO or partnership could probably be expected by as early as 1Q 2025 correct?
Itâs possible. If Karisma meets or exceeds primary endpoint, it becomes a candidate for licensing/acquiring.
The nice thing about multiple trials is, drugs can have multiple applications. Endoxifen could be approved to reduce MBD by the FDA while still being tested for cancer reduction.
Key term in your question though is âas early asâ. One must consider the possibility weâre not acquired until all trials complete.
Really it boils down to two things: Does Endofixen work, and are you willing to wait until thatâs proven out?
Subreddit
Post Details
- Posted
- 1 year ago
- Reddit URL
- View post on reddit.com
- External URL
- reddit.com/r/AtossaThera...
This is one of those situations where I think the FDA guidelines are way too conservative.
Of course Endoxifen is safe; itâs what our liver metabolizes from Tamoxifen! If Endox wasnât safe than Tamox wouldnât be either.
Frustrating for sure having to jump through all these hoops, particular for a cancer medicine.